Synaptics (NASDAQ:SYNA) reported quarterly earnings of $3.52 per share which beat the analyst consensus estimate of $3.35 by 5.07 percent. This is a 31.34 percent increase over earnings of $2.68 per share from the same period last year. The company reported quarterly sales of $448.10 million which missed the analyst consensus estimate of $454.74 million by 1.46 percent. This is a 20.23 percent increase over sales of $372.70 million the same period last year.
G1 Therapeutics Reveals An Early Cut Data From Bladder Cancer Trial
G1 Therapeutics Inc (NASDAQ:GTHX) provided an initial update on the PRESERVE 3 Phase 2 study of first-line platinum-based chemotherapy…
